Loading...

Walgreens Boots Alliance, Inc.

WBA•NASDAQ
Healthcare
Medical - Pharmaceuticals
$11.49
$0.00(0.00%)

Walgreens Boots Alliance, Inc. (WBA) Stock Overview

Explore Walgreens Boots Alliance, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 63.4/100

Key Financials

Market Cap9.9B
P/E Ratio-1.58
EPS (TTM)$-7.29
ROE-0.70%
Fundamental Analysis

AI Price Forecasts

1 Week$11.26
1 Month$7.33
3 Months$6.08
1 Year Target$7.04

WBA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Walgreens Boots Alliance, Inc. (WBA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $7.04.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.58 and a market capitalization of 9.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Revenue Growth
6.17%
↑ 6.17%
Profit Growth
$-7.28
↓ 180.39%
EPS Growth
$-7.28
↓ 180.39%
Operating Margin
-2.02%
↓ 104.53%
ROE
-70.17%
↓ 180.39%
Dividend Yield
0.00%
↓ 24.04%

Analyst Recommendations

Strong Buy
0
Buy
1
Hold
6
Sell
4
Strong Sell
0

Price Targets

Low$7.00
Average$10.65
High$16.00

Company Profile

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

CEO

Timothy C. Wentworth

Employees

193,000

Headquarters

108 Wilmot Road, Deerfield, IL

Founded

1980

Frequently Asked Questions

;